SAN DIEGO--(BUSINESS WIRE)--April 20, 2006--MultiCell Technologies, Inc. (OTCBB:MCET - News), developer of therapeutics for the treatment of degenerative neurological diseases, metabolic and endocrinological disorders, and infectious diseases, will outline its robust drug development pipeline and strategic initiatives for investment professionals at the Equities 55th Anniversary Conference, to be held at The Yale Club on April 21, 2006, in New York City.
